Sort
39,280 grants matching “leukemia”
Transcription Factor Regulation by the BCR/ABL Oncogene
$301,843Bruno Calabretta · Thomas Jefferson University · R01 · FY2012 · CA
Transcription Factor Regulation by the BCR/ABL Oncogene
$301,843Bruno Calabretta · Thomas Jefferson University · R01 · FY2011 · CA
Structure/Function of Protein Tyrosine Phosphatases
$301,815Zhong-Yin Zhang · Indiana University Indianapolis · R01 · FY2015 · CA
Structure/Function of Protein Tyrosine Phosphatases
$301,815Zhong-Yin Zhang · Indiana University Indianapolis · R01 · FY2013 · CA
Mechanisms of the Adenovirus E4-ORF1 Oncoprotein
$301,814Ronald T. Javier · Baylor College Of Medicine · R01 · FY2007 · CA
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
$301,785David A Fruman · University Of California-Irvine · R01 · FY2014 · CA
Molecular Mechanisms for the Assembly and Regulation of the MLL1 Core Complex
$301,772Michael S. Cosgrove · Upstate Medical University · R01 · FY2013 · CA
Fanconi Anemia and HPV Transformation
$301,759Susanne Irmtraud Wells · Cincinnati Childrens Hosp Med Ctr · R01 · FY2010 · CA
Cancer Genetics
$301,699Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2012 · CA
Molecular mechanisms of gene silencing by H4 methylation
$301,675Judd C Rice · University Of Southern California · R01 · FY2011 · GM
Mdig gene and histone demethylation in lung cancer
$301,674Fei Chen · Wayne State University · R01 · FY2011 · ES
Mdig gene and histone demethylation in lung cancer
$301,674Fei Chen · Wayne State University · R01 · FY2012 · ES
Development and Applications of 'Designer Chromatin'
$301,671Tom W Muir · Princeton University · R01 · FY2016 · GM
Cancer Vaccines in the Treatment of CML
$301,658Johns Hopkins University · R21 · FY2005 · CA
Cancer Vaccines in the Treatment of CML
$301,658Johns Hopkins University · R21 · FY2004 · CA
Exploting Zebrafish Models for Fanconi Anemia
$301,656John Harvey Postlethwait · Oregon Health & Science University · P01 · FY2011 · HL
Fanconi Anemia: Molecular pathogenesis of Bone Marrow Failure and Clonal Evolutio
$301,653Grover Carlton Bagby · Oregon Health & Science University · P01 · FY2011 · HL
preclinical Testing of Novel Therapies in FA
$301,653Markus Grompe · Oregon Health & Science University · P01 · FY2011 · HL
Pretargeted Radioimmunotherapy for Hematologic Malignancies
$301,631Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA
Enhancement of methotrexate uptake in childhood ALL
$301,612John J McGuire · Roswell Park Cancer Institute Corp · R01 · FY2007 · CA
Data Compilation Core
$301,599Stephen L George · Univ Of North Carolina Chapel Hill · P01 · FY2011 · CA
EWS/FLI AND ITS TARGETS IN EWING'S SARCOMA
$301,577Stephen L Lessnick · University Of Utah · R01 · FY2011 · CA
The role of XMRV, a newly discovered human retrovirus, in cancer pathogenesis
$301,577Ila R Singh · University Of Utah · R01 · FY2011 · CA
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy
$301,543Grant D Trobridge · Seattle Children'S Hospital · P01 · FY2015 · AI
Nuclear Transport Factors in Chromosomal Instability
$301,534Jan M Van Deursen · Mayo Clinic Rochester · R01 · FY2006 · CA